Recent advances and current challenges in tumour immunology and immunotherapy
Recent advances and current challenges in tumour immunology and immunotherapy
Despite advances in animal studies, where the cure of the majority of mice with pre-established (albeit early-stage) tumors has become almost standard, human clinical trials have been much less successful. Here we describe some of the most recent advances in the specialist field of tumor immunology and immunotherapy, highlighting salient work to identify key problem areas and potential solutions. We make particular note of recent developments in adoptive therapy; whole-cell, DNA, and peptide vaccines; and antibody therapy. We also describe the revival of interest in regulatory T cells and conclude by detailing the need for clinical trial read-out autonomy and methods to predict which patients will respond to a particular treatment
cancer immunotherapy, tregs, cancer-testis antigen, antibody therapy, adoptive transfer, genetic vaccines
1065-1071
Guinn, Barbar-ann
596441de-9938-4994-9e04-0075cc32d205
Kasahara, Noriyuki
eaea4c06-d144-4fd1-bb54-cad38b2388fa
Farzaneh, Farzin
4d23cf63-efe4-4a52-93cf-504776bffcfb
Habib, Nagy A.
7e89d1b6-ffff-418c-a8c9-92e292aa0701
Norris, James S.
34aa5e7a-ad82-40b5-97a3-f3ae7a14001a
Deisseroth, Albert B.
17057781-2243-43a4-a97d-aab2dc0792dc
June 2007
Guinn, Barbar-ann
596441de-9938-4994-9e04-0075cc32d205
Kasahara, Noriyuki
eaea4c06-d144-4fd1-bb54-cad38b2388fa
Farzaneh, Farzin
4d23cf63-efe4-4a52-93cf-504776bffcfb
Habib, Nagy A.
7e89d1b6-ffff-418c-a8c9-92e292aa0701
Norris, James S.
34aa5e7a-ad82-40b5-97a3-f3ae7a14001a
Deisseroth, Albert B.
17057781-2243-43a4-a97d-aab2dc0792dc
Guinn, Barbar-ann, Kasahara, Noriyuki, Farzaneh, Farzin, Habib, Nagy A., Norris, James S. and Deisseroth, Albert B.
(2007)
Recent advances and current challenges in tumour immunology and immunotherapy.
Molecular Therapy, 15 (6), .
(doi:10.1038/sj.mt.6300138).
Abstract
Despite advances in animal studies, where the cure of the majority of mice with pre-established (albeit early-stage) tumors has become almost standard, human clinical trials have been much less successful. Here we describe some of the most recent advances in the specialist field of tumor immunology and immunotherapy, highlighting salient work to identify key problem areas and potential solutions. We make particular note of recent developments in adoptive therapy; whole-cell, DNA, and peptide vaccines; and antibody therapy. We also describe the revival of interest in regulatory T cells and conclude by detailing the need for clinical trial read-out autonomy and methods to predict which patients will respond to a particular treatment
This record has no associated files available for download.
More information
Submitted date: 7 March 2007
Published date: June 2007
Keywords:
cancer immunotherapy, tregs, cancer-testis antigen, antibody therapy, adoptive transfer, genetic vaccines
Identifiers
Local EPrints ID: 71567
URI: http://eprints.soton.ac.uk/id/eprint/71567
ISSN: 1525-0016
PURE UUID: 11089b10-9772-486d-814c-afcfb3c8d372
Catalogue record
Date deposited: 14 Dec 2009
Last modified: 13 Mar 2024 20:33
Export record
Altmetrics
Contributors
Author:
Barbar-ann Guinn
Author:
Noriyuki Kasahara
Author:
Farzin Farzaneh
Author:
Nagy A. Habib
Author:
James S. Norris
Author:
Albert B. Deisseroth
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics